Argatroban during percutaneous transluminal coronary angioplasty: Results of a dose-verification study

Patrick W. Serruys, William Wijns, Marcel van den Brand, Cornelis J. Slager, Joerg Grimm, Brian E. Jaski, Ronald W. Brower, Otto M. Hess, Paul G. Hugenholtz

Chapter in a book1982

Computerized Quantitative Coronary Angiography Applied to Percutaneous Transluminal Coronary Angioplasty: Advantages and Limitations

Patrick W. Serruys, F. Booman, G. J. Troost, Johan H. C. Reiber, Jan J. Gerbrands, Marcel van den Brand, F Cherrier, Philip Hugenholtz

Argatroban during percutaneous transluminal coronary angioplasty: Results of a dose-verification study

Abstract

Discussion(0)

Related publications

Abrupt coronary artery occlusion during percutaneous transluminal coronary angioplasty

Elastic recoil after percutaneous transluminal coronary angioplasty. A quantitative angiographic approach

Definition of Restenosis after Percutaneous Transluminal Coronary Angioplasty: A Quickly Evolving Concept

Effect of coronary occlusion during percutaneous transluminal angioplasty on systolic and diastolic left ventricular function

Computerized Quantitative Coronary Angiography Applied to Percutaneous Transluminal Coronary Angioplasty: Advantages and Limitations